SLN 6.88 (+8.52%)
US82686Q1013BiotechnologyBiotechnology

Silence Therapeutics (SLN) Financial Metrics

This table shows a selected set of financial data points of Silence Therapeutics (SLN). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -1.17 0 -11.69 505.97M -0.43 25.38M -39.4M -47.66M -43.27M 54.03M
2022 -1.26 0 -10.06 407.23M -0.4 17.5M -45.9M -47.89M -40.49M 54.82M
2021 -1.33 0 -13.32 524.76M -0.43 12.42M 5.47M -45.38M -39.41M 73.54M
2020 -1.19 0 -13.52 439.96M -0.49 5.48M -11.29M -35.22M -32.55M 27.45M
2019 -0.78 0 0 0 -0.46 244K 1.72M -22.23M -19.58M 13.52M
2018 -0.26 0 0 0 -0.39 0 -16.95M -20.13M -18.41M 21.49M
2017 -0.02 0 0 0 -0.03 16K -9.77M -3.33M -1.62M 42.75M
2016 0 0 0 0 -0.14 770K -10.6M -10.05M -8.44M 39.01M
2015 0 0 0 0 -0.15 0 -9.11M -9.25M -6.65M 51.91M
2014 0 0 0 0 -0.38 15K -9.79M -11.65M -11.09M 16.86M
2013 0 0 0 0 -0.39 117K -6.89M -8.71M -9M 15.89M
2012 0 0 0 0 -1.04 163K -5.08M -26.03M -26.28M 8.91M
2011 0 0 0 0 -0.17 694K -5.39M -5.42M -5.74M 3.69M
2010 0 0 0 0 -0.39 2.37M -10.84M -8.41M -8.8M 3.57M
2009 0 0 0 0 -0.59 1.72M -4.87M -7.14M -7.47M 1.13M
2008 0 0 0 0 -0.44 2.21M -7.25M -7.01M -7.44M 3.35M
2007 0 0 0 0 -0.28 4.05M -4.36M -4.93M -5.11M 10.17M
2006 0 0 0 0 -0.23 1.95M -4.16M -3.59M -3.83M 8.82M
2005 0 0 0 0 -0.35 509K -2.87M -3.42M -3.59M 9.09M
2004 0 0 0 0 -0.61 159K -2.37M -3.2M -2.96M 2.63M
2003 0 0 0 0 -0.3 1.35M -2.07M -2.41M -2.28M 5.09M
2002 0 0 0 0 -0.16 1.15M -1.92M -1.65M -1.48M 7.16M
2001 0 0 0 0 -0.2 138K -2.29M -2.51M -2.19M 9.08M
2000 0 0 0 0 -0.17 959K -2.98M -2.2M -1.94M 11.43M
1999 0 0 0 0 -0.29 1.37M -1.14M -2.01M -2.14M 10.53M
1998 0 0 0 0 -0.34 210K -1.81M -1.54M -1.58M 3.66M
1997 0 0 0 0 -0.29 0 -1.53M -1.73M -1.76M 5.18M
1996 0 0 0 0 -0.2 0 -824K -931K -965K 6.7M
1995 0 0 0 0 0 0 -763K -873K -874K 1.25M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.